{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:35:55Z","timestamp":1770824155451,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T00:00:00Z","timestamp":1298678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00428-011-1058-1","type":"journal-article","created":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T08:40:57Z","timestamp":1298623257000},"page":"403-411","source":"Crossref","is-referenced-by-count":23,"title":["Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes?"],"prefix":"10.1007","volume":"458","author":[{"given":"Matthias","family":"Haas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maike","family":"B\u00fcttner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman T.","family":"Rau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard G.","family":"Grabenbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luitpold V.","family":"Distel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,26]]},"reference":[{"issue":"2","key":"1058_CR1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","volume":"21","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21(2):137\u2013148. doi: 10.1016\/j.immuni.2004.07.017","journal-title":"Immunity"},{"issue":"4","key":"1058_CR2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/labinvest.3700055","volume":"84","author":"AG Menon","year":"2004","unstructured":"Menon AG, Janssen-van Rhijn CM, Morreau H, Putter H, Tollenaar RA, van de Velde CJ, Fleuren GJ, Kuppen PJ (2004) Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest 84(4):493\u2013501. doi: 10.1038\/labinvest.37000553700055","journal-title":"Lab Invest"},{"issue":"10","key":"1058_CR3","first-page":"3932","volume":"61","author":"K Schumacher","year":"2001","unstructured":"Schumacher K, Haensch W, Roefzaad C, Schlag PM (2001) Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res 61(10):3932\u20133936","journal-title":"Cancer Res"},{"issue":"3","key":"1058_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00428-009-0813-z","volume":"455","author":"E Solcia","year":"2009","unstructured":"Solcia E, Klersy C, Mastracci L, Alberizzi P, Candusso ME, Diegoli M, Tava F, Riboni R, Manca R, Luinetti O (2009) A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis. Virchows Arch 455(3):197\u2013211. doi: 10.1007\/s00428-009-0813-z","journal-title":"Virchows Arch"},{"issue":"4","key":"1058_CR5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/path.1236","volume":"198","author":"JJ Oudejans","year":"2002","unstructured":"Oudejans JJ, Harijadi H, Kummer JA, Tan IB, Bloemena E, Middeldorp JM, Bladergroen B, Dukers DF, Vos W, Meijer CJ (2002) High numbers of granzyme B\/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent. J Pathol 198(4):468\u2013475. doi: 10.1002\/path.1236","journal-title":"J Pathol"},{"issue":"4","key":"1058_CR6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1182\/blood.V89.4.1376","volume":"89","author":"JJ Oudejans","year":"1997","unstructured":"Oudejans JJ, Jiwa NM, Kummer JA, Ossenkoppele GJ, van Heerde P, Baars JW, Kluin PM, Kluin-Nelemans JC, van Diest PJ, Middeldorp JM, Meijer CJ (1997) Activated cytotoxic T cells as prognostic marker in Hodgkin\u2019s disease. Blood 89(4):1376\u20131382","journal-title":"Blood"},{"issue":"7","key":"1058_CR7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.it.2004.04.009","volume":"25","author":"CA Piccirillo","year":"2004","unstructured":"Piccirillo CA, Thornton AM (2004) Cornerstone of peripheral tolerance: naturally occurring CD4\u2009+\u2009CD25+ regulatory T cells. Trends Immunol 25(7):374\u2013380. doi: 10.1016\/j.it.2004.04.009","journal-title":"Trends Immunol"},{"key":"1058_CR8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","volume":"182","author":"S Sakaguchi","year":"2001","unstructured":"Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T (2001) Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182:18\u201332. doi: 1820102","journal-title":"Immunol Rev"},{"issue":"5609","key":"1058_CR9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057\u20131061. doi: 10.1126\/science.1079490","journal-title":"Science"},{"key":"1058_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-230X-9-65","volume":"9","author":"M Haas","year":"2009","unstructured":"Haas M, Dimmler A, Hohenberger W, Grabenbauer GG, Niedobitek G, Distel LV (2009) Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. BMC Gastroenterol 9:65. doi: 1471-230X-9-65","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"1058_CR11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/ijc.10144","volume":"97","author":"S Ohno","year":"2002","unstructured":"Ohno S, Tachibana M, Fujii T, Ueda S, Kubota H, Nagasue N (2002) Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma. Int J Cancer 97(6):770\u2013774. doi: 10.1002\/ijc.10144","journal-title":"Int J Cancer"},{"issue":"2","key":"1058_CR12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.semcancer.2008.10.011","volume":"19","author":"C Krieg","year":"2009","unstructured":"Krieg C, Boyman O (2009) The role of chemokines in cancer immune surveillance by the adaptive immune system. Semin Cancer Biol 19(2):76\u201383. doi: 10.1016\/j.semcancer.2008.10.011","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"1058_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00812257","volume":"21","author":"U Syrbe","year":"1999","unstructured":"Syrbe U, Siveke J, Hamann A (1999) Th1\/Th2 subsets: distinct differences in homing and chemokine receptor expression? Springer Semin Immunopathol 21(3):263\u2013285","journal-title":"Springer Semin Immunopathol"},{"issue":"6","key":"1058_CR14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00428-010-0921-9","volume":"456","author":"H Ohtani","year":"2010","unstructured":"Ohtani H, Yoshie O (2010) Morphometric analysis of the balance between CXCR3+ T cells and FOXP3+ regulatory T cells in lymphocyte-rich and conventional gastric cancers. Virchows Arch 456(6):615\u2013623. doi: 10.1007\/s00428-010-0921-9","journal-title":"Virchows Arch"},{"issue":"1","key":"1058_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2448","volume":"217","author":"H Ohtani","year":"2009","unstructured":"Ohtani H, Jin Z, Takegawa S, Nakayama T, Yoshie O (2009) Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma. J Pathol 217(1):21\u201331. doi: 10.1002\/path.2448","journal-title":"J Pathol"},{"issue":"1","key":"1058_CR16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(197607)38:1<232::AID-CNCR2820380135>3.0.CO;2-4","volume":"38","author":"H Watanabe","year":"1976","unstructured":"Watanabe H, Enjoji M, Imai T (1976) Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer 38(1):232\u2013243","journal-title":"Cancer"},{"issue":"5","key":"1058_CR17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/1097-0142(19900901)66:5<945::AID-CNCR2820660523>3.0.CO;2-X","volume":"66","author":"T Minamoto","year":"1990","unstructured":"Minamoto T, Mai M, Watanabe K, Ooi A, Kitamura T, Takahashi Y, Ueda H, Ogino T, Nakanishi I (1990) Medullary carcinoma with lymphocytic infiltration of the stomach. Clinicopathologic study of 27 cases and immunohistochemical analysis of the subpopulations of infiltrating lymphocytes in the tumor. Cancer 66(5):945\u2013952","journal-title":"Cancer"},{"issue":"5","key":"1058_CR18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/mp.53.5.255","volume":"53","author":"K Takada","year":"2000","unstructured":"Takada K (2000) Epstein\u2013Barr virus and gastric carcinoma. Mol Pathol 53(5):255\u2013261","journal-title":"Mol Pathol"},{"issue":"4","key":"1058_CR19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1200\/JCO.2004.08.061","volume":"22","author":"J Beek van","year":"2004","unstructured":"van Beek J, zur Hausen A, Klein Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, Meijer CJ, Bloemena E (2004) EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol 22(4):664\u2013670. doi: 10.1200\/JCO.2004.08.061","journal-title":"J Clin Oncol"},{"issue":"3","key":"1058_CR20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1440-1746.2009.05775.x","volume":"24","author":"JH Lee","year":"2009","unstructured":"Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS (2009) Clinicopathological and molecular characteristics of Epstein\u2013Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol 24(3):354\u2013365. doi: 10.1111\/j.1440-1746.2009.05775.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1058_CR21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.gastro.2010.04.002","volume":"139","author":"HJ Song","year":"2010","unstructured":"Song HJ, Srivastava A, Lee J, Kim YS, Kim KM, Ki Kang W, Kim M, Kim S, Park CK (2010) Host inflammatory response predicts survival of patients with Epstein\u2013Barr virus-associated gastric carcinoma. Gastroenterology 139(1):84\u201392.e82. doi: 10.1053\/j.gastro.2010.04.002","journal-title":"Gastroenterology"},{"issue":"9","key":"1058_CR22","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","volume":"19","author":"C Gravalos","year":"2008","unstructured":"Gravalos C, Jimeno A (2008) HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 19(9):1523\u20131529. doi: 10.1093\/annonc\/mdn169","journal-title":"Ann Oncol"},{"issue":"2","key":"1058_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/annonc\/mdi064","volume":"16","author":"M Tanner","year":"2005","unstructured":"Tanner M, Hollmen M, Junttila TT, Kapanen AI, Tommola S, Soini Y, Helin H, Salo J, Joensuu H, Sihvo E, Elenius K, Isola J (2005) Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol 16(2):273\u2013278. doi: 10.1093\/annonc\/mdi064","journal-title":"Ann Oncol"},{"issue":"9742","key":"1058_CR24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Ruschoff J, Kang YK (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376(9742):687\u2013697. doi: 10.1016\/S0140-6736(10)61121-X","journal-title":"Lancet"},{"issue":"3","key":"1058_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00428-010-0952-2","volume":"457","author":"J Ruschoff","year":"2010","unstructured":"Ruschoff J, Dietel M, Baretton G, Arbogast S, Walch A, Monges G, Chenard MP, Penault-Llorca F, Nagelmeier I, Schlake W, Hofler H, Kreipe HH (2010) HER2 diagnostics in gastric cancer\u2014guideline validation and development of standardized immunohistochemical testing. Virchows Arch 457(3):299\u2013307. doi: 10.1007\/s00428-010-0952-2","journal-title":"Virchows Arch"},{"issue":"2","key":"1058_CR26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1097-0215(19981005)78:2<202::AID-IJC14>3.0.CO;2-C","volume":"78","author":"K Kono","year":"1998","unstructured":"Kono K, Rongcun Y, Charo J, Ichihara F, Celis E, Sette A, Appella E, Sekikawa T, Matsumoto Y, Kiessling R (1998) Identification of HER2\/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes. Int J Cancer 78(2):202\u2013208. doi: 10.1002\/(SICI)1097-0215(19981005)78:2<202::AID-IJC14>3.0.CO;2-C","journal-title":"Int J Cancer"},{"key":"1058_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0065-230X(02)85004-7","volume":"85","author":"R Kiessling","year":"2002","unstructured":"Kiessling R, Wei WZ, Herrmann F, Lindencrona JA, Choudhury A, Kono K, Seliger B (2002) Cellular immunity to the Her-2\/neu protooncogene. Adv Cancer Res 85:101\u2013144","journal-title":"Adv Cancer Res"},{"issue":"1","key":"1058_CR28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0960-7404(00)00021-9","volume":"9","author":"HJ Stein","year":"2000","unstructured":"Stein HJ, Feith M, Siewert JR (2000) Cancer of the esophagogastric junction. Surg Oncol 9(1):35\u201341. doi: S0960-7404(00)00021-9","journal-title":"Surg Oncol"},{"issue":"1","key":"1058_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002620050244","volume":"42","author":"P Pellegrini","year":"1996","unstructured":"Pellegrini P, Berghella AM, Del Beato T, Cicia S, Adorno D, Casciani CU (1996) Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother 42(1):1\u20138","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"1058_CR30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gut.2006.114504","volume":"56","author":"S Hansen","year":"2007","unstructured":"Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, Jellum E, McColl KE (2007) Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 56(7):918\u2013925. doi: 10.1136\/gut.2006.114504","journal-title":"Gut"},{"issue":"8","key":"1058_CR31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/00365520601173863","volume":"42","author":"JH Siman","year":"2007","unstructured":"Siman JH, Engstrand L, Berglund G, Forsgren A, Floren CH (2007) Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol 42(8):933\u2013940. doi: 10.1080\/00365520601173863","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"1058_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000055345","volume":"61","author":"Y Tajima","year":"2001","unstructured":"Tajima Y, Nakanishi Y, Yoshino T, Kokawa A, Kusano M, Shimoda T (2001) Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus. Oncology 61(1):1\u20139. doi: ocl61001","journal-title":"Oncology"},{"issue":"3","key":"1058_CR33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/bjc.1990.314","volume":"62","author":"J Powell","year":"1990","unstructured":"Powell J, McConkey CC (1990) Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 62(3):440\u2013443","journal-title":"Br J Cancer"},{"issue":"4","key":"1058_CR34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.seminoncol.2004.04.020","volume":"31","author":"M Sarbia","year":"2004","unstructured":"Sarbia M, Becker KF, Hofler H (2004) Pathology of upper gastrointestinal malignancies. Semin Oncol 31(4):465\u2013475. doi: S0093775404002416","journal-title":"Semin Oncol"},{"issue":"3","key":"1058_CR35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0016-5085(84)80016-5","volume":"86","author":"RJ Kalish","year":"1984","unstructured":"Kalish RJ, Clancy PE, Orringer MB, Appelman HD (1984) Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett\u2019s esophageal mucosa and in the gastric cardia. Gastroenterology 86(3):461\u2013467. doi: S0016508584000615","journal-title":"Gastroenterology"},{"issue":"1","key":"1058_CR36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.bjc.6604149","volume":"98","author":"Y Mizukami","year":"2008","unstructured":"Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, Sugai H, Fujii H (2008) Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br J Cancer 98(1):148\u2013153. doi: 10.1038\/sj.bjc.6604149","journal-title":"Br J Cancer"},{"issue":"3","key":"1058_CR37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","volume":"6","author":"F Aloisi","year":"2006","unstructured":"Aloisi F, Pujol-Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6(3):205\u2013217. doi: 10.1038\/nri1786","journal-title":"Nat Rev Immunol"},{"issue":"14","key":"1058_CR38","first-page":"3845","volume":"54","author":"KF Becker","year":"1994","unstructured":"Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54(14):3845\u20133852","journal-title":"Cancer Res"},{"key":"1058_CR39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1746-1596-5-21","volume":"5","author":"A Krenauer","year":"2010","unstructured":"Krenauer A, Moll A, Ponisch W, Schmitz N, Niedobitek G, Niederwieser D, Aigner T (2010) EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression\u2014a case report. Diagn Pathol 5:21. doi: 10.1186\/1746-1596-5-21","journal-title":"Diagn Pathol"},{"issue":"4","key":"1058_CR40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/bjc.1996.412","volume":"74","author":"M Sugiura","year":"1996","unstructured":"Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T (1996) Transcriptional analysis of Epstein\u2013Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer 74(4):625\u2013631","journal-title":"Br J Cancer"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-011-1058-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-011-1058-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-011-1058-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T22:54:06Z","timestamp":1592348046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-011-1058-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,26]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1058"],"URL":"https:\/\/doi.org\/10.1007\/s00428-011-1058-1","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,26]]}}}